Inter-ventricular Septum Ablation for the Treatment of Hypertrophic Obstructive Cardiomyopathy

doi:10.37015/AUDT.2020.200048

Advanced Ultrasound in Diagnosis and Therapy ›› 2020, Vol. 4 ›› Issue (4): 297-302.doi: 10.37015/AUDT.2020.200048

• Review Articles • Previous Articles Next Articles

Inter-ventricular Septum Ablation for the Treatment of Hypertrophic Obstructive Cardiomyopathy

Yuejin Wu, MS^a^,^b, Shaobo Duan, MD^b, Luwen Liu, MS^b^,^c, Shuaiyang Wang, MS^b, Shuang Xu, MS^d, Liuwei Hao, BS^d, Lianzhong Zhang, MD^a^,^b^,^*()

^a Department of Ultrasound, Henan Provincial People’s Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou, Henan, China
^b Henan Engineering Technology Research Center of Ultrasonic Molecular Imaging and Nanotechnology, Zhengzhou, Henan, China
^c Zhengzhou University People's Hospital, Henan Provincial People’s Hospital, Zhengzhou, Henan, China
^d Department of Health Management, Henan Provincial People’s Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou, Henan, China

Received:2020-05-15 Online:2020-12-30 Published:2020-09-29
Contact: Lianzhong Zhang, MD, E-mail:zlz8777@163.com

Richhtml ( 10 ) PDF ( 578 )

Abstract

Abstract:

For symptomatic hypertrophic obstructive cardiomyopathy (HOCM), how to effectively relieve left ventricular outflow tract obstruction is of great significance. Relying on drugs and double-chamber pacing to reduce left ventricular outflow tract pressure gradient can alleviate symptoms. Methods to reduce the thickness of inter-ventricular septum include myocardial myectomy, percutaneous transluminal septal myocardial ablation, radiofrequency catheter ablation of ventricular tachycardia, and high-intensity focused ultrasound (HIFU) ablation of the ventricular septum that were performed on animal experiments to reduce inter-ventricular septal thickness, and showed significant therapeutic effects. Ultrasound-guided percutaneous intramyocardial septal ablation, as a less invasive and more effective treatment, exhibited great application prospects in reducing the pressure gradient of left ventricular outflow tract. This article reviews the research progress of several ventricular septal ablation techniques for the treatment of HOCM.

Key words: Hypertrophic obstructive cardiomyopathy; Left ventricular hypertrophy; Septal ablation

Yuejin Wu, MS, Shaobo Duan, MD, Luwen Liu, MS, Shuaiyang Wang, MS, Shuang Xu, MS, Liuwei Hao, BS, Lianzhong Zhang, MD. Inter-ventricular Septum Ablation for the Treatment of Hypertrophic Obstructive Cardiomyopathy. Advanced Ultrasound in Diagnosis and Therapy, 2020, 4(4): 297-302.

References

[1]	Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2011; 58:2703-2738.
[2]	Marian AJ. Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy. Lancet 2000; 355:58-60.
[3]	Zou Y, Song L, Wang Z, Ma A, Liu T, Gu H, et al. Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults. Am J Med 2004; 116:14-18.
[4]	Zhang Y, Wang J, Wang MH. Diagnosis and treatment of hypertrophic cardiomyopathy based on the guideline. World Clin Drug 2013; 34:235-240.
[5]	Varma PK, Neema PK. Hypertrophic cardiomyopathy: part 1 - introduction, pathology and pathophysiology. Ann Card Anaesth 2014; 17:118-124.
[6]	Veselka J, Anavekar NS, Charron P. Hypertrophic obstructive cardiomyopathy. Lancet 2017; 389:1253-1267.
[7]	Chinese Medical Association Cardiovascular Branch Chinese Adult Hypertrophic Cardiomyopathy Diagnosis and Treatment Guideline Writing Group, Chinese Journal of Cardiovascular Disease Editorial Board. Guidelines for diagnosis and treatment of hypertrophic cardiomyopathy in Chinese adults. Chin J Cardiol 2017; 45:1015-1032.
[8]	He G, Sun C, Zhang X, Zuo L, Qin H, Zheng M, et al. Echocardiography-guided percutaneous per-ventricular laser ablation of ventricular septum: in vivo study in a canine model Lasers Med Sci 2016; 31:645-651.
[9]	Olivotto I, Ommen SR, Maron MS, Cecchi F, Maron BJ. Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Will there ever be a randomized trial? J Am Coll Cardiol 2007; 50(9):831-834.
[10]	Linde C, Gadler F, Kappenberger L, Rydén L. Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy. PIC Study Group. Pacing In Cardiomyopathy. Am J Cardiol 1999; 83:903-907.
[11]	Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995; 346:211-214.
[12]	China expert consensus of hypertrophic obstructive cardiomyopathy septal myocardial ablation, China expert consensus of hypertrophic obstructive cardiomyopathy septal myocardial ablation. Chinese Journal of Cardiovascular Review 2012; 10:1-7.
[13]	Zhu C, Tang B, Cui H, Wang S, Xiao M, Chen Z, et al. Predictors of long-term outcome after septal myectomy in symptomatic hypertrophic obstructive cardiomyopathy patients with previous alcohol septal ablation and residual obstruction. J Card Surg 2019; 34:533-540.
[14]	Kuhn HJ. Optimizing catheter-based therapy of hypertrophic obstructive cardiomyopathy: does alcohol dose matter? Can J Cardiol 2011; 27:668-70.
[15]	Chen R, Jiang ZX, Shan QJ. Ventricular septal radiofrequency ablation: a new option for the treatment of obstructive hypertrophic cardiomyopathy. Chin J Cardiol 2017; 45:186-189.
[16]	Lawrenz T, Borchert B, Leuner C, Bartelsmeier M, Reinhardt J, Strunk-Mueller C, et al. Endocardial radiofrequency ablation for hypertrophic obstructive cardiomyopathy: acute results and 6 months' follow-up in 19 patients. J Am Coll Cardiol 2011; 57:572-576.
[17]	Kan T, Zhang W, Zhang M, Zhang J, Chu GJ, Qin YW. Radiofrequency ablation of ventricular outflow tract septum: a preliminary study in experimental canine. J Intervent Radiol 2017; 26:153-156.
[18]	FRY WJ, BARNARD JW, FRY EJ, KRUMINS RF, BRENNAN JF. Ultrasonic lesions in the mammalian central nervous system. Science 1955; 122:517-518.
[19]	Zheng M, Shentu W, Chen D, Sahn DJ, Zhou X. High-intensity focused ultrasound ablation of myocardium in vivo and instantaneous biological response. Echocardiography 2014; 31:1146-53.
[20]	Otsuka R, Fujikura K, Abe Y, Okajima K, Pulerwitz T, Engel DJ, et al. Extracardiac ablation of the left ventricular septum in beating canine hearts using high-intensity focused ultrasound. J Am Soc Echocardiogr. 2007; 20:1400-1406.
[21]	Engel DJ, Muratore R, Hirata K, Otsuka R, Fujikura K, Sugioka K, et al. Myocardial lesion formation using high-intensity focused ultrasound. J Am Soc Echocardiogr 2006; 19:932-937.
[22]	Konda A, Cappell MS, Dieterle L, Haines DE. Esophageal ulceration from high-intensity focused US catheter ablation for pulmonary vein isolation: a novel complication in the treatment of symptomatic refractory atrial fibrillation. Gastrointest Endosc 2008; 68:597-599.
[23]	Rigopoulos AG, Seggewiss H. A decade of percutaneous septal ablation in hypertrophic cardiomyopathy. Circ J 2011; 75:28-37.
[24]	Zuo L, Sun C, Yang J, Liu B, Zhou M, Guo R, et al. Percutaneous trans-apex intra-septal radiofrequency ablation of hypertrophic cardiomyopathy. Minim Invasive Ther Allied Technol 2018; 27:97-100.
[25]	Liu J, Li W, Huang TY, Huang XW, Yao FJ, Liu DH, et al. Radiofrequency ablation of myocardium in vitro and thermal field distribution. Journal of Sun Yat-Sen University(Medical Sciences) 2018; 39:791-796.
[26]	Liu L, Li J, Zuo L, Zhang J, Zhou M, Xu B, et al. Percutaneous intramyocardial septal radiofrequency ablation for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2018; 72:1898-1909.
[27]	Fu J, Sun C, Liu F, Hu R, Hsi DH, Tuo S, et al. Transthoracic echocardiography guided percutaneous laser ablation of the interventricular septum: A successful sheep model for septal thickness reduction and one year follow-up. Int J Cardiol 2019; 280:135-141.

Inter-ventricular Septum Ablation for the Treatment of Hypertrophic Obstructive Cardiomyopathy

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 0

Metrics

Comments